• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Life Science Market
Life Science News
Life Science Stocks
  • Life Science Market
  • Life Science News
  • Life Science Stocks

Seasonal Flu Vaccine Less Effective Than Hoped

Charlotte McLeod
Jan. 15, 2015 04:18PM PST
Life Science Investing

CBC News reported that early estimates show that this season’s flu vaccine reduces risk of flu by just 23 percent among Americans. For Canadians, the vaccine is even less effective.

CBC News reported that early estimates show that this season’s flu vaccine reduces risk of flu by just 23 percent among Americans. For Canadians, the vaccine is even less effective.

As quoted in the market news:

Canadian and U.S. health officials have said the most common type of flu circulating this season is H3N2, which is not well-matched with the seasonal flu vaccine.

On Thursday, the U.S. Centers for Disease Control and Prevention released an estimate based on 2,321 American children and adults who got the flu vaccine between November and January. The CDC said vaccinated people had a 23 per cent lower chance of winding up at the doctor with the flu.

 Click here to read the full CBC News report.

life-science-investing
The Conversation (0)

Go Deeper

AI Powered
Two vials labelled "H5N1 Vaccine." One stands and one lays on its side behind the first.

Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

Life Science Outlook: World Edition

Life Science Outlook: World Edition

Latest News

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

More News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Life Science Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES